Probiotics in the Management of Chemotherapy‐Induced Gastrointestinal Complications: Underlying Mechanisms and Potential Applications
Molecular Nutrition & Food Research · 2026-04 · 70 (8)
DOI: 10.1002/mnfr.70421 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 20.04.2026. Verfasst von Faeze Mazloom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Laboratory Sciences, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Diseases, Antineoplastic Agents. Die Arbeit nennt 105 Literaturangaben. Gefördert von: Kerman University of Medical Sciences.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The intestinal microbial population safeguards the gut's health through dynamic interactions with adjacent epithelial and immune cells. Therefore, microbial imbalance in the gastrointestinal (GI) tract may lead to impaired immune system function, disrupted epithelial integrity, and elevated susceptibility to systemic health issues. Chemotherapy, a nonspecific, widely used therapeutic option in cancer treatment, can harm rapidly proliferating intestinal epithelial cells and disrupt intestinal microbial balance, leading to chemotherapy‐induced GI adverse events, including mucositis, diarrhea, constipation, bowel inflammation, nausea, vomiting, flatulence, dyspepsia, gastritis, stomatitis, and abdominal pain and distention. These adverse events significantly impair the quality of life of cancer patients. Clinical evidences show promising efficacy for probiotics, especially Lactobacillus spp. and Bifidobacterium spp., in restoring gut microbiota diversity, enhancing mucosal integrity, and modulating inflammatory cytokines (e.g., IL‐10, IL‐6, and TNF‐a). However, study design variabilities, strain‐specific effects, and safety concerns in immunocompromised cases remain challenging. This review explores the underlying mechanisms of preventing chemotherapy‐induced GI complications using probiotics. Understanding these mechanisms can facilitate probiotic integration into supportive oncology care protocols. This review also highlights the need for standard protocols, personalized therapies, and advanced multi‐omics approaches to discover the host–microbe interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Medical Laboratory Sciences, Kerman University of Medical Sciences, Kerman, Iran.
- Stem Cells and Regenerative Medicine Innovation Center, Kerman University of Medical Sciences, Kerman, Iran.
- Student Research Committee, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
ORCID-Profile: Faeze Mazloom, Mahsa Mottaghizadeh-Jazi, Amin Sadeghi Dousari, Alireza Farsinejad, Alireza Khanahmad
Förderung
- Kerman University of Medical Sciences
Zitieren
APA
Mazloom, F., Mottaghizadeh-Jazi, M., Sadeghi Dousari, A., Farsinejad, A., & Khanahmad, A. (2026). Probiotics in the Management of Chemotherapy‐Induced Gastrointestinal Complications: Underlying Mechanisms and Potential Applications. Molecular Nutrition & Food Research, 70(8). https://doi.org/10.1002/mnfr.70421
Vancouver
Mazloom F, Mottaghizadeh-Jazi M, Sadeghi Dousari A, Farsinejad A, Khanahmad A. Probiotics in the Management of Chemotherapy‐Induced Gastrointestinal Complications: Underlying Mechanisms and Potential Applications. Molecular Nutrition & Food Research. 2026;70(8). doi:10.1002/mnfr.70421
BibTeX
@article{Mazloom2026,
author = {Mazloom, Faeze and Mottaghizadeh-Jazi, Mahsa and Sadeghi Dousari, Amin and Farsinejad, Alireza and Khanahmad, Alireza},
title = {Probiotics in the Management of Chemotherapy‐Induced Gastrointestinal Complications: Underlying Mechanisms and Potential Applications},
journal = {Molecular Nutrition & Food Research},
year = {2026},
volume = {70},
number = {8},
doi = {10.1002/mnfr.70421}
}
EUVIMED